Why was interest in health communication originally limited in the healthcare arena?

Try the new Google Books

Check out the new look and enjoy easier access to your favorite features

Why was interest in health communication originally limited in the healthcare arena?

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.

  1. Balog-Way DHP, McComas KA. Covid-19: reflections on trust, tradeoffs, and preparedness. J Risk Res. 2020;23(7–8):838–48.

    Google Scholar 

  2. McCartney M, Sullivan F, Heneghan C. Information and rational decision-making: explanations to patients and citizens about personal risk of Covid-19. BMJ Evid Based Med. 2020;26:143.

    Google Scholar 

  3. de Campos-Rudinsky TC, Undurraga E. Public health decisions in the Covid-19 pandemic require more than ‘follow the science.’ J Med Ethics. 2021. https://doi.org/10.1136/medethics-2020-107134.

    Article  PubMed  Google Scholar 

  4. Fischhoff B. The Covid communication breakdown. In: Foreign Affairs. 2021.

  5. Hyland K, Jiang F. The Covid infodemic: competition and the hyping of virus research. Int J Corpus Linguist. 2021;26:444.

    Google Scholar 

  6. Pak A, McBryde E, Adegboye OA. Does high public trust amplify compliance with stringent Covid-19 government health guidelines? A multi-country analysis using data from 102,627 individuals. Risk Manag Healthc Policy. 2021;14:293–302.

    PubMed  PubMed Central  Google Scholar 

  7. Oxman AD, Glenton C, Flottorp S, Lewin S, Rosenbaum S, Fretheim A. Development of a checklist for people communicating evidence-based information about the effects of healthcare interventions: a mixed methods study. BMJ Open. 2020;10(7):e036348.

    PubMed  PubMed Central  Google Scholar 

  8. Veit W, Brown R, Earp BD. In science we trust? Being honest about the limits of medical research during Covid-19. Am J Bioeth. 2021;21(1):22–4.

    PubMed  Google Scholar 

  9. van der Bles AM, van der Linden S, Freeman ALJ, Spiegelhalter DJ. The effects of communicating uncertainty on public trust in facts and numbers. Proc Natl Acad Sci U S A. 2020;117(14):7672–83.

    PubMed  PubMed Central  Google Scholar 

  10. Schneider CR, Freeman ALJ, Spiegelhalter D, van der Linden S. The effects of quality of evidence communication on perception of public health information about Covid-19: two randomised controlled trials. PLoS One. 2021;16(11):e0259048.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Dawson A. Information, choice and the ends of health promotion. Monash Bioeth Rev. 2014;32(1–2):106–20.

    PubMed  Google Scholar 

  12. Tengland PA. Behavior change or empowerment: on the ethics of health-promotion goals. Health Care Anal. 2016;24(1):24–46.

    PubMed  Google Scholar 

  13. Chiu K, Grundy Q, Bero L. “Spin” in published biomedical literature: a methodological systematic review. PLoS Biol. 2017;15(9):e2002173.

    PubMed  PubMed Central  Google Scholar 

  14. Yavchitz A, Boutron I, Bafeta A, Marroun I, Charles P, Mantz J, Ravaud P. Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study. PLoS Med. 2012;9(9):e1001308.

    PubMed  PubMed Central  Google Scholar 

  15. Sumner P, Vivian-Griffiths S, Boivin J, Williams A, Venetis CA, Davies A, Ogden J, Whelan L, Hughes B, Dalton B, et al. The association between exaggeration in health related science news and academic press releases: retrospective observational study. BMJ. 2014;349:g7015.

    PubMed  PubMed Central  Google Scholar 

  16. Oxman M, Larun L, Gaxiola GP, Alsaid D, Qasim A, Rose CJ, Bischoff K, Oxman AD. Quality of information in news media reports about the effects of health interventions: systematic review and meta-analyses. F10000Res. 2021;10:433.

    CAS  Google Scholar 

  17. Berndt ER. To inform or persuade? Direct-to-consumer advertising of prescription drugs. N Engl J Med. 2005;352(4):325–8.

    CAS  PubMed  Google Scholar 

  18. Rossi J, Yudell M. The use of persuasion in public health communication: an ethical critique. Public Health Ethics. 2012;5(2):192–205.

    Google Scholar 

  19. European Parliament and Council. Directive 2005/29/EC: Unfair Commercial Practices Directive. Brussels: Official Journal of the European Union; 2005.

  20. Medicines and Healthcare products Regulatory Agency. The blue guide: advertising and promotion of medicines in the UK. 3rd ed. London: Medicines and Healthcare products Regulatory Agency; 2020.

    Google Scholar 

  21. Lenzer J. Why aren’t the US Centers for Disease Control and Food and Drug Administration speaking with one voice on flu? BMJ. 2015;350:h658.

    PubMed  Google Scholar 

  22. Schwartz LM, Woloshin S, Welch HG. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med. 2009;150(8):516–27.

    PubMed  Google Scholar 

  23. Akl EA, Oxman AD, Herrin J, Vist GE, Terrenato I, Sperati F, Costiniuk C, Blank D, Schunemann H. Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database Syst Rev. 2011;3:CD006776.

    Google Scholar 

  24. Woloshin S, Schwartz LM, Welch HG. The effectiveness of a primer to help people understand risk: two randomized trials in distinct populations. Ann Intern Med. 2007;146(4):256–65.

    PubMed  Google Scholar 

  25. Witte K, Allen M. A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav. 2000;27(5):591–615.

    CAS  PubMed  Google Scholar 

  26. Zhu M, Yang Y, Hsee CK. The mere urgency effect. J Consum Res. 2018;45(3):673–90.

    Google Scholar 

  27. Chen M, Bell RA. A meta-analysis of the impact of point of view on narrative processing and persuasion in health messaging. Psychol Health. 2021. https://doi.org/10.1080/08870446.2021.1894331.

    Article  PubMed  Google Scholar 

  28. Shen F, Sheer VC, Li R. Impact of narratives on persuasion in health communication: a meta-analysis. J Advertising. 2015;44(2):105–13.

    Google Scholar 

  29. Nadarevic L, Reber R, Helmecke AJ, Köse D. Perceived truth of statements and simulated social media postings: an experimental investigation of source credibility, repeated exposure, and presentation format. Cogn Res Princ Implic. 2020;5(1):56.

    PubMed  PubMed Central  Google Scholar 

  30. Alonso-Coello P, Schunemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Rada G, Rosenbaum S, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016;353:i2016.

    PubMed  Google Scholar 

  31. Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2020. https://doi.org/10.1002/14651858.CD004407.pub4.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Ames HMR, Glenton C, Lewin S. Parents’ and informal caregivers’ views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence. Cochrane Database Syst Rev. 2017. https://doi.org/10.1002/14651858.CD011787.pub2.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Hofmann B. Do women receive enough information to make informed choices about breast cancer screening? Tidsskr Nor Laegeforen. 2020. https://doi.org/10.4045/tidsskr.19.0568.

    Article  PubMed  Google Scholar 

  34. Blumenthal-Barby JS. Between reason and coercion: ethically permissible influence in health care and health policy contexts. Kennedy Inst Ethics J. 2012;22(4):345–66.

    CAS  PubMed  Google Scholar 

  35. Beauchamp TL, Childress JF. Principles of biomedical ethics. New York: Oxford University Press; 2019.

    Google Scholar 

  36. Guttman N, Lev E. Ethical Issues in Covid-19 communication to mitigate the pandemic: dilemmas and practical implications. Health Commun. 2021;36(1):116–23.

    PubMed  Google Scholar 

  37. Nestle M. Food politics: how the food industry influences nutrition and health, vol. 3. Berkeley: Univ of California Press; 2013.

    Google Scholar 

  38. Kahneman D. Thinking, fast and slow. New York: Farrar, Straus and Giroux; 2017.

    Google Scholar 

  39. O’Hara L, Taylor J, Barnes M. The extent to which the public health “war on obesity” reflects the ethical values and principles of critical health promotion: a multimedia critical discourse analysis. Health Promot J Austr. 2015;26(3):246–54.

    PubMed  Google Scholar 

  40. Peinado S, Treiman K, Uhrig JD, Taylor JC, Stryker JE. Effectively communicating about HIV and other health disparities: findings from a literature review and future directions. Front Commun. 2020. https://doi.org/10.3389/fcomm.2020.539174.

    Article  Google Scholar 

  41. Chewning B, Bylund CL, Shah B, Arora NK, Gueguen JA, Makoul G. Patient preferences for shared decisions: a systematic review. Patient Educ Couns. 2012;86(1):9–18.

    PubMed  Google Scholar 

  42. Theo Raynor DK, Blackwell K, Middleton W. What do writers need to know about user testing? Medical Writ. 2015;24(4):215–8.

    Google Scholar 

  43. Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. Lancet. 2010;376(9748):1261–71.

    PubMed  PubMed Central  Google Scholar 

  44. Schwartz LM, Woloshin S. The case for letting information speak for itself. Eff Clin Pract. 2001;4(2):76–9.

    CAS  PubMed  Google Scholar 

  45. Palmer S, Jansen A, Leitmeyer K, Murdoch H, Forland F. Evidence-Based Medicine applied to the control of communicable disease incidents when evidence is scarce and the time is limited. Euro Surveill. 2013. https://doi.org/10.2807/1560-7917.ES2013.18.25.20507.

    Article  PubMed  Google Scholar 

  46. Fretheim A, Brurberg KG, Forland F. Rapid reviews for rapid decision-making during the coronavirus disease (Covid-19) pandemic, Norway, 2020. Euro Surveill. 2020. https://doi.org/10.2807/1560-7917.ES.2020.25.19.2000687.

    Article  PubMed  PubMed Central  Google Scholar 

  47. World Health Organization. Communicating risk in public health emergencies: a WHO guideline for emergency risk communication (ERC) policy and practice. Geneva: World Health Organization; 2017.

    Google Scholar 

  48. Bretthauer M, Helsingen LM, Løberg M, Kalager M, Guyatt G. Evidence and precaution for legal health interventions: learning from the Covid-19 pandemic. Ann Intern Med. 2021;174(10):1456–7.

    PubMed  Google Scholar 

  49. Aronson JK, Barends E, Boruch R, Brennan M, Chalmers I, Chislett J, Cunliffe-Jones P, Dahlgren A, Gaarder M, Haines A, et al. Key concepts for making informed choices. Nature. 2019;572(7769):303–6.

    CAS  PubMed  Google Scholar 

  50. Roozenbeek J, Schneider CR, Dryhurst S, Kerr J, Freeman ALJ, Recchia G, van der Bles AM, van der Linden S. Susceptibility to misinformation about Covid-19 around the world. R Soc Open Sci. 2020;7(10):201199.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Dahlgren A, Furuseth-Olsen K, Rose CJ, Oxman AD. The Norwegian public’s ability to assess treatment claims: results of a cross-sectional study of critical health literacy. F1000Research. 2021. https://doi.org/10.12688/f1000research.21902.2.

    Article  Google Scholar 

  52. Andrews JC, Schunemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, Rind D, Montori VM, Brito JP, Norris S, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation’s direction and strength. J Clin Epidemiol. 2013;66(7):726–35.

    PubMed  Google Scholar 

  53. Agoritsas T, Merglen A, Heen AF, Kristiansen A, Neumann I, Brito JP, Brignardello-Petersen R, Alexander PE, Rind DM, Vandvik PO, et al. UpToDate adherence to GRADE criteria for strong recommendations: an analytical survey. BMJ Open. 2017;7(11):e018593.

    PubMed  PubMed Central  Google Scholar 

  54. Alexander PE, Brito JP, Neumann I, Gionfriddo MR, Bero L, Djulbegovic B, Stoltzfus R, Montori VM, Norris SL, Schünemann HJ, et al. World Health Organization strong recommendations based on low-quality evidence (study quality) are frequent and often inconsistent with GRADE guidance. J Clin Epidemiol. 2016;72:98–106.

    PubMed  Google Scholar 

  55. Parry LJ, Asenbaum H, Ercan SA. Democracy in flux: a systemic view on the impact of Covid-19. Transform Gov: People Process Policy; 2020;15(2):197–205.

  56. Lacelle-Webster A, Landry J, Smith AMD. Citizen voice in the pandemic response: democratic innovations from around the world. In: Smith G, Hughes T, Adams L, Obijiaku C, editors. Democracy in a Pandemic. London: University of Westminster Press; 2021.

    Google Scholar 

  57. Scheinerman N, McCoy M. What does it mean to engage the public in the response to Covid-19? BMJ. 2021. https://doi.org/10.1136/bmj.n1207.

  58. Norheim OF, Abi-Rached JM, Bright LK, Bærøe K, Ferraz OLM, Gloppen S, Voorhoeve A. Difficult trade-offs in response to COVID-19: the case for open and inclusive decision making. Nat Med. 2021;27(1):10–3.

    CAS  PubMed  Google Scholar 

  59. Fung A. Is democracy too much trouble in a pandemic? In: Smith G, Hughes T, Adams L, Obijiaku C, editors. Democracy in a Pandemic. London: University of Westminster Press; 2021.

    Google Scholar 

  60. Weir E, Schabas R, Wilson K, Mackie C. A Canadian framework for applying the precautionary principle to public health issues. Canad J Public Health. 2010;101(5):396–8.

    PubMed  PubMed Central  Google Scholar 

  61. Hermerén G. The principle of proportionality revisited: interpretations and applications. Med Health Care Philos. 2012;15(4):373–82.

    PubMed  Google Scholar 


Page 2

Skip to main content

From: Health communication in and out of public health emergencies: to persuade or to inform?

Factors that can affect a decision Spin to influence people to behave in a desired way
The effects of behaving in the desired way compared to other options Emphasize or exaggerate the benefits of behaving in the desired way
Ignore or downplay the harms or undesirable effects of behaving in the desired way
Ignore or downplay uncertainty about the benefits, and emphasize or exaggerate uncertainty about the harms
Neglect to consider or point out that people may weigh desirable and undesirable outcomes differently
Assume or imply that the desirable effects far outweigh the undesirable effects
Costs of behaving in the desired way compared to other options Ignore or downplay the costs and emphasize or exaggerate the savings of behaving in the desired way
Ignore or downplay uncertainty about the savings and emphasize or exaggerate uncertainty about the costs
Ignore, assume or imply the intervention is cost-effective, and ignore uncertainty
Alternatives to the desired option Misinform or leave out information about relevant alternatives